Overview of GLP-1 Receptor Agonists The major GLP-1 receptor agonists available on the market currently are: Dulaglutide (Trulicity) Exenatide extended release (Bydureon BCise) Exenatide (Byetta) Semaglutide (Ozempic, Rybelsus) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) What is Dulaglutide (Trulicity) and its mechanism of action Dulaglutide, sold as Trulicity, is an injectable GLP-1 receptor agonist medication designed for the treatment of type 2 diabetes
Low blood sugar during sleep can trigger sweating, along with other symptoms such as tremors, palpitations, confusion, or nightmares
When verifying, ask specifically about obesity treatment benefits, GLP-1 medication coverage, BMI eligibility requirements, prior authorization requirements, and your current deductible and copay structure
This comparison examines the clinical data supporting each agent, including the landmark head-to-head trial, independent program data, cardiovascular outcomes, and practical considerations for treatment selection
Example 11 Synthesis of semaglutide: 100mg of compound 4 obtained in example 7 with a purity of about 74.08% was added to an iced freshly prepared 1mL of lysate (trifluoroacetic acid: water: triisopropylsilane =95 2
